| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
MDS Mutation Analysis Only : 1016476
Test CodeMDFCPMDSSEQ or 1016476
Alias/See Also
MDS; Myelodysplastic Syndrome
CPT Codes
81450
Includes
Includes: ASXL1, CALR, CBL, CSF3R, DNMT3A, ETV6 (TEL), EZH2, IDH1, IDH2, JAK2, MPL, NRAS, PHF6, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, and U2AF1.
Instructions
Peripheral Blood in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
OR
Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
OR
Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
Transport Container
Submit 5-10 mL Blood in a lavender top and/or 5-10 mL Blood in a green top.
OR
Submit 2-3 mL Bone Marrow in a lavender top and/or 2-3 mL Bone Marrow in a green top.
Do not centrifuge.
OR
Submit 2-3 mL Bone Marrow in a lavender top and/or 2-3 mL Bone Marrow in a green top.
Do not centrifuge.
Transport Temperature
Refrigerated.
Specimen Stability
Ambient: 48 hours; Refrigerated: 15 days; Frozen: Unacceptable
Methodology
Next Generation Sequencing
Setup Schedule
Monday & Thursday
Report Available
8-10 days
Reference Range
An integrated report with results from all tests along with relevant diagnostic, prognostic and clinical trial information.
Clinical Significance
The MDS panel will aid the clinician in making a definitive diagnosis of MDS and provide additional prognostic and predictive information.
Performing Laboratory
med fusion
